Table 5.
Correlational Matrix of Key Variables (N = 151)
| Variables | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Age | ||||||||||||
| 2. Comorbidity | 0.421** | |||||||||||
| 3. HD Vintage | 0.031 | −0.221** | ||||||||||
| 4. Treatment Controla | 0.156 | 0.000 | 0.086 | |||||||||
| 5. Adherence to HD | 0.297** | 0.123 | 0.005 | −0.024 | ||||||||
| 6. Adherence to Medications | 0.227** | 0.066 | 0.133 | −0.054 | 0.225** | |||||||
| 7. Adherence to Fluid | 0.111 | −0.014 | −0.009 | 0.038 | 0.136 | 0.150 | ||||||
| 8. Adherence to Diet | −0.001 | −0.023 | −0.081 | −0.171* | 0.162* | 0.207* | 0.303** | |||||
| 9. IDWG for 4 Weeks | 0.013 | 0.213** | 0.106 | 0.065 | 0.162* | −0.044 | −0.205* | −0.141 | ||||
| 10. Kt/Vurea, Single Pool | 0.092 | −0.142 | 0.257** | 0.095 | 0.169* | 0.154 | −0.010 | 0.069 | −0.246** | |||
| 11. Pre-HD Serum Phosphrus | −0.274** | −0.096 | −0.176* | 0.034 | −0.154 | −0.272** | 0.042 | −0.055 | 0.178* | −0.279** | ||
| 12. Pre-HD Serum Potassium | −0.224** | −0.041 | −0.023 | −.064 | −0.115 | −0.020 | −0.040 | −0.051 | 0.221** | −0.084 | 0.111 | |
| 13. Post-HD SUN | −0.075 | 0.201* | −0.249** | 0.077 | −0.161* | −0.120 | −0.096 | −0.106 | 0.416** | −0.661** | 0.348** | 0.305** |
Treatment control = score of treatment control dimension among 7 dimensions of illness perception’s control dimension; co-morbidity = Charlson comorbidity scores were used; higher illness perception scores reflect stronger negative perceptions about illness; higher adherence scores reflect better adherence level.
Correlation is significant at the 0.05 level (2-tailed).
Correlation is significant at the 0.01 level (2-tailed).